Prognostic and Clinical Value of Interleukin 6 and CD45<sup>+</sup>CD14<sup>+</sup> Inflammatory Cells with PD-L1<sup>+</sup>/PD-L2<sup>+</sup> Expression in Patients with Different Manifestation of Ovarian Cancer

<div>Concentration of IL-6 in the plasma of patients with ovarian tumors and healthy donors.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Prognostic and Clinical Value of Interleukin 6 and CD45<sup>+</sup>CD14<sup>+</sup> Inflammatory Cells with PD-L1<sup>+</sup>/PD-L2<sup>+</sup> Expression in Patients with Different Manifestation of Ovarian Cancer 

Figure 2 | Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer 